Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Planned Sale Of China’s Cedara Medical Software Firm Canceled

This article was originally published in PharmAsia News

Executive Summary

U.S.-based Merge Healthcare has canceled plans to sell its Chinese subsidiary, Cedara Software Shanghai to Inqgen Technology of Taiwan. Merge, which produces medical-imaging software for drug and device makers, has changed management since the sale was announced nearly a year ago. The new executives consider China as a major factor in the growth planned for its core business, an official said. He said Cedara would enable Merge to have sales, marketing, customer support and engineering presences in China, potentially the world's largest market for its products. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts